Myocarditis stands as a medical condition marked by inflammation in the myocardium, which is the heart muscle. The inflammation commonly stems from viral infections, although bacterial or fungal infections, certain medications, or exposure to toxins can also trigger it. This inflammatory response weakens the heart muscle, impacting its ability to effectively pump blood. Symptoms of myocarditis can manifest in various ways, ranging from mild fatigue and chest discomfort to more severe complications like heart failure or irregular heart rhythms. To diagnose myocarditis, a comprehensive approach is typically employed, involving a thorough review of the patient's medical history, a detailed physical examination, blood tests, and various imaging studies. While mild cases may resolve spontaneously, more severe instances may necessitate medical intervention, including the use of medications aimed at reducing inflammation and supporting heart function. Due to the diverse array of causes and potential complications associated with myocarditis, early detection and appropriate management are paramount in addressing the condition and preventing long-term cardiac issues.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt